Probing the effectiveness of barrier creams against human skin penetration of nickel powder

Abstract

AbstractObjectiveBarrier creams (BCs) are marketed as locally applied medical devices or cosmetic products to protect the skin from exposure to chemicals and irritants. Generally, the mechanism of action of such products is mainly due to the formation of a superficial thin film between the skin and the irritant or sensitizer, thus reducing or totally blocking the cutaneous penetration of such agents. Specifically, studies focusing on the effectiveness of commercial protective creams to prevent nickel cutaneous penetration are extremely scarce. The aim of the current work, therefore, is to evaluate the protective role of a commercially available barrier cream for nickel and compare the results with a simple moisturizing, following exposure to Ni powder.MethodsMarketed BCs were evaluated and tested. Human skin absorption of Ni was studied in vitro using static Franz diffusion cells.ResultsOur results demonstrate that the application of both formulations caused a reduction of Ni inside the skin (8.00 ± 3.35 μg cm−2 for the barrier cream and 22.6 ± 12.6 μg cm−2 for the general moisturizing product), with the specialized barrier cream being statistically (p = 0.015) more efficient on forming a protective barrier, thus evidencing the importance of some ingredients in such formulations on the nickel dermal accumulation.ConclusionsThe composition of the formulations based on film‐forming or chelating agents may play an imperative role in reducing the cutaneous penetration of Ni.